<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">Am J Hum Genet</journal-id>
      <journal-title-group>
        <journal-title>American Journal of Human Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0002-9297</issn>
      <issn pub-type="epub">1537-6605</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33159882</article-id>
      <article-id pub-id-type="pmc">7820632</article-id>
      <article-id pub-id-type="pii">S0002-9297(20)30365-7</article-id>
      <article-id pub-id-type="doi">10.1016/j.ajhg.2020.10.007</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Bi-allelic Pathogenic Variants in <italic>HS2ST1</italic> Cause a Syndrome Characterized by Developmental Delay and Corpus Callosum, Skeletal, and Renal Abnormalities</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="au1">
          <name>
            <surname>Schneeberger</surname>
            <given-names>Pauline E.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn1" ref-type="fn">7</xref>
        </contrib>
        <contrib contrib-type="author" id="au2">
          <name>
            <surname>von Elsner</surname>
            <given-names>Leonie</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="fn1" ref-type="fn">7</xref>
        </contrib>
        <contrib contrib-type="author" id="au3">
          <name>
            <surname>Barker</surname>
            <given-names>Emma L.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author" id="au4">
          <name>
            <surname>Meinecke</surname>
            <given-names>Peter</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author" id="au5">
          <name>
            <surname>Marquardt</surname>
            <given-names>Iris</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author" id="au6">
          <name>
            <surname>Alawi</surname>
            <given-names>Malik</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author" id="au7">
          <name>
            <surname>Steindl</surname>
            <given-names>Katharina</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author" id="au8">
          <name>
            <surname>Joset</surname>
            <given-names>Pascal</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author" id="au9">
          <name>
            <surname>Rauch</surname>
            <given-names>Anita</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author" id="au10">
          <name>
            <surname>Zwijnenburg</surname>
            <given-names>Petra J.G.</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author" id="au11">
          <name>
            <surname>Weiss</surname>
            <given-names>Marjan M.</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author" id="au12">
          <name>
            <surname>Merry</surname>
            <given-names>Catherine L.R.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author" id="au13">
          <name>
            <surname>Kutsche</surname>
            <given-names>Kerstin</given-names>
          </name>
          <email>kkutsche@uke.de</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="cor1" ref-type="corresp">&#x2217;</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany</aff>
        <aff id="aff2"><label>2</label>Nottingham Biodiscovery Institute, University of Nottingham, University Park NG7 2RD, UK</aff>
        <aff id="aff3"><label>3</label>Klinik f&#xFC;r Neurop&#xE4;diatrie und angeborene Stoffwechselerkrankungen, Klinikum Oldenburg, 26133 Oldenburg, Germany</aff>
        <aff id="aff4"><label>4</label>Bioinformatics Core, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany</aff>
        <aff id="aff5"><label>5</label>Institute of Medical Genetics, University of Z&#xFC;rich, 8952 Schlieren, Switzerland</aff>
        <aff id="aff6"><label>6</label>Department of Clinical Genetics, Amsterdam University Medical Center, 1081 Amsterdam, the Netherlands</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>&#x2217;</label>Corresponding author <email>kkutsche@uke.de</email></corresp>
        <fn id="fn1">
          <label>7</label>
          <p id="ntpara0010">These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>03</day>
        <month>12</month>
        <year>2020</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>06</day>
        <month>11</month>
        <year>2020</year>
      </pub-date>
      <volume>107</volume>
      <issue>6</issue>
      <fpage>1044</fpage>
      <lpage>1061</lpage>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>7</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>10</month>
          <year>2020</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2020 American Society of Human Genetics.</copyright-statement>
        <copyright-year>2020</copyright-year>
        <copyright-holder>American Society of Human Genetics</copyright-holder>
      </permissions>
      <abstract id="abs0010">
        <title>Summary</title>
        <p>Heparan sulfate belongs to the group of glycosaminoglycans (GAGs), highly sulfated linear polysaccharides. Heparan sulfate 2-<italic>O</italic>-sulfotransferase 1 (HS2ST1) is one of several specialized enzymes required for heparan sulfate synthesis and catalyzes the transfer of the sulfate groups to the sugar moiety of heparan sulfate. We report bi-allelic pathogenic variants in <italic>HS2ST1</italic> in four individuals from three unrelated families. Affected individuals showed facial dysmorphism with coarse face, upslanted palpebral fissures, broad nasal tip, and wide mouth, developmental delay and/or intellectual disability, corpus callosum agenesis or hypoplasia, flexion contractures, brachydactyly of hands and feet with broad fingertips and toes, and uni- or bilateral renal agenesis in three individuals. <italic>HS2ST1</italic> variants cause a reduction in <italic>HS2ST1</italic> mRNA and decreased or absent heparan sulfate 2-<italic>O</italic>-sulfotransferase 1 in two of three fibroblast cell lines derived from affected individuals. The heparan sulfate synthesized by the individual 1 cell line lacks 2-<italic>O</italic>-sulfated domains but had an increase in <italic>N</italic>- and 6-<italic>O</italic>-sulfated domains demonstrating functional impairment of the HS2ST1. As heparan sulfate modulates FGF-mediated signaling, we found a significantly decreased activation of the MAP kinases ERK1/2 in FGF-2-stimulated cell lines of affected individuals that could be restored by addition of heparin, a GAG similar to heparan sulfate. Focal adhesions in FGF-2-stimulated fibroblasts of affected individuals concentrated at the cell periphery. Our data demonstrate that a heparan sulfate synthesis deficit causes a recognizable syndrome and emphasize a role for 2-<italic>O</italic>-sulfated heparan sulfate in human neuronal, skeletal, and renal development.</p>
      </abstract>
      <kwd-group id="kwrds0010">
        <title>Keywords</title>
        <kwd>whole-exome sequencing</kwd>
        <kwd>syndrome</kwd>
        <kwd>iduronic acid</kwd>
        <kwd>glycosaminoglycan</kwd>
        <kwd>paxillin</kwd>
        <kwd>2-<italic>O</italic>-sulfate</kwd>
        <kwd>3&#x2019;-phosphoadenosine 5&#x2019;-phosphosulfate</kwd>
        <kwd>extracellular matrix</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <p id="misc0010">Published: November 6, 2020</p>
    </notes>
  </front>
</article>
</pmc-articleset>